List of Tables
Table 1. Peptide-based Drug Market Trends
Table 2. Peptide-based Drug Market Drivers & Opportunity
Table 3. Peptide-based Drug Market Challenges
Table 4. Peptide-based Drug Market Restraints
Table 5. Global Peptide-based Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Peptide-based Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Peptide-based Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Peptide-based Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Peptide-based Drug
Table 10. Global Peptide-based Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Peptide-based Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Peptide-based Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Peptide-based Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Peptide-based Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Peptide-based Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Peptide-based Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Peptide-based Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Peptide-based Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Peptide-based Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Peptide-based Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Peptide-based Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Peptide-based Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Peptide-based Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Peptide-based Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Peptide-based Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Peptide-based Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Peptide-based Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Peptide-based Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Sanofi Basic Information List
Table 32. Sanofi Description and Business Overview
Table 33. Sanofi Peptide-based Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Peptide-based Drug Business of Sanofi (2019-2024)
Table 35. Sanofi Recent Developments
Table 36. Teva Basic Information List
Table 37. Teva Description and Business Overview
Table 38. Teva Peptide-based Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Peptide-based Drug Business of Teva (2019-2024)
Table 40. Teva Recent Developments
Table 41. Novo Nordisk Basic Information List
Table 42. Novo Nordisk Description and Business Overview
Table 43. Novo Nordisk Peptide-based Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Peptide-based Drug Business of Novo Nordisk (2019-2024)
Table 45. Novo Nordisk Recent Developments
Table 46. Takeda Basic Information List
Table 47. Takeda Description and Business Overview
Table 48. Takeda Peptide-based Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Peptide-based Drug Business of Takeda (2019-2024)
Table 50. Takeda Recent Developments
Table 51. Eli Lilly Basic Information List
Table 52. Eli Lilly Description and Business Overview
Table 53. Eli Lilly Peptide-based Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Peptide-based Drug Business of Eli Lilly (2019-2024)
Table 55. Eli Lilly Recent Developments
Table 56. AstraZeneca Basic Information List
Table 57. AstraZeneca Description and Business Overview
Table 58. AstraZeneca Peptide-based Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Peptide-based Drug Business of AstraZeneca (2019-2024)
Table 60. AstraZeneca Recent Developments
Table 61. Novartis Basic Information List
Table 62. Novartis Description and Business Overview
Table 63. Novartis Peptide-based Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Peptide-based Drug Business of Novartis (2019-2024)
Table 65. Novartis Recent Developments
Table 66. AbbVie Basic Information List
Table 67. AbbVie Description and Business Overview
Table 68. AbbVie Peptide-based Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Peptide-based Drug Business of AbbVie (2019-2024)
Table 70. AbbVie Recent Developments
Table 71. Ipsen Basic Information List
Table 72. Ipsen Description and Business Overview
Table 73. Ipsen Peptide-based Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Peptide-based Drug Business of Ipsen (2019-2024)
Table 75. Ipsen Recent Developments
Table 76. Ferring Basic Information List
Table 77. Ferring Description and Business Overview
Table 78. Ferring Peptide-based Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Peptide-based Drug Business of Ferring (2019-2024)
Table 80. Ferring Recent Developments
Table 81. Merck Basic Information List
Table 82. Merck Description and Business Overview
Table 83. Merck Peptide-based Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Peptide-based Drug Business of Merck (2019-2024)
Table 85. Merck Recent Developments
Table 86. The Medicines Basic Information List
Table 87. The Medicines Description and Business Overview
Table 88. The Medicines Peptide-based Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Peptide-based Drug Business of The Medicines (2019-2024)
Table 90. The Medicines Recent Developments
Table 91. J & J Basic Information List
Table 92. J & J Description and Business Overview
Table 93. J & J Peptide-based Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Peptide-based Drug Business of J & J (2019-2024)
Table 95. J & J Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Peptide-based Drug Downstream Customers
Table 99. Peptide-based Drug Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Peptide-based Drug Product Picture
Figure 2. Global Peptide-based Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peptide-based Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Peptide-based Drug Report Years Considered
Figure 5. Global Peptide-based Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide-based Drug Revenue in 2023
Figure 7. Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Injection Picture
Figure 9. Oral Picture
Figure 10. Other Picture
Figure 11. Global Peptide-based Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Peptide-based Drug Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Cancer
Figure 14. Product Picture of Metabolic Disorders
Figure 15. Product Picture of Central Nervous System
Figure 16. Product Picture of Other
Figure 17. Global Peptide-based Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Peptide-based Drug Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Peptide-based Drug Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Peptide-based Drug Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Peptide-based Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Peptide-based Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Peptide-based Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Peptide-based Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Peptide-based Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Peptide-based Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Peptide-based Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Peptide-based Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Peptide-based Drug Sales Value (%), (2019-2030)
Figure 30. United States Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 36. China Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 38. China Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 48. India Peptide-based Drug Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Peptide-based Drug Sales Value by Type (%), 2023 VS 2030
Figure 50. India Peptide-based Drug Sales Value by Application (%), 2023 VS 2030
Figure 51. Peptide-based Drug Industrial Chain
Figure 52. Peptide-based Drug Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
